Resveratrol: A Vital Therapeutic Agent with Multiple Health Benefits

Abstract

Resveratrol (RSV), the most effective stilbene phytoalexin synthesized naturally or induced in plants as part of their defense mechanism, is a key component of natural phenolic compounds and is being considered as a treatment option for a variety of diseases. RSV was discovered in the skin of red grapes, mulberries, peanuts, pines, and Polygonum cuspidatum weed root extracts. It was first extracted from white hellebore (Veratrum grandiflorum O. Loes) roots in 1940, then from Polygonum cuspidatum roots in 1963. However, RSV’s use as a drug is limited due to its initial conformational strength and poor stability. The research focused on a set of RSV biological activity data. RSV has been the subject of growing concern, despite its wide range of biological and therapeutic applications. According to the literature, RSV has antioxidant, anti-cancer, cardioprotective, neuroprotective, anti- inflammatory, anti-microbial, immunomodulatory, and radioprotective properties. The current analysis summarized biological applications of RSV, their mechanisms of action, and recent scientific development in the area of their delivery. It is possible to infer that RSV has many effects on infected cells’ cellular functions.

Key words

RSV - Therapeutic properties - Mechanism of action - Side effects - Future prospects

Publikationsverlauf

Eingereicht: 17. Mai 2021

Angenommen: 19. Juli 2021

Artikel online veröffentlicht:
19. August 2021

• References

• 1 Baxter RA. Anti-aging properties of resveratrol: review and report of a potent new antioxidant skin care formulation. J Cosmet Dermatol 2008; 1: 2-7
• 2 Kala R, Tollefsbol TO, Li Y. Potential of resveratrol in inhibiting cancer and slowing aging. J Nutr Food Sci S 2012; 5: 2-9
• 3 Menjoge AR, Kannan RM, Tomalia DA. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today 2010; 15: 171-185
• 4 Esfand R, Tomalia DA. Poly (amidoamine)(PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications. Drug Discov Today 2001; 6: 427-436
• 5 Li B, Liu H, Amin M. et al Enhancement of naringenin solution concentration by solid dispersion in cellulose derivative matrices. CELLULOSE 2013; 20: 2137-2149
• 6 Li X, Wu B, Wang L. et al Extractable amounts of trans-resveratrol in seed and berry skin in Vitis evaluated at the germplasm level. J Agric Food Chem 2006; 54: 8804-8811
• 7 Wang W, Tang K, Yang HR. et al Distribution of resveratrol and stilbene synthase in young grape plants (Vitis vinifera L. cv. Cabernet Sauvignon) and the effect of UV-C on its accumulation. Plant Physiol Biochem 2010; 48: 142-152
• 8 Langcake P. Disease resistance of Vitis spp. and the production of the stress metabolites resveratrol, ε-viniferin, α-viniferin and pterostilbene. Physiol Plant Pathol 1981; 18: 213-226
• 9 Dercks W, Creasy LL. The significance of stilbene phytoalexins in the Plasmopara viticola-grapevine interaction. Physiol Mol Plant Pathol 1989; 34: 189-202
• 10 Schmidlin L, Poutaraud A, Claudel P. et al A stress-inducible resveratrol O-methyltransferase involved in the biosynthesis of pterostilbene in grapevine. Plant Physiol 2008; 148: 1630-1639
• 11 Gambini J, Inglés M, Olaso G. et al Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxid Med Cell Longev 2015; 2015: 1-13
• 12 Keylor MH, Matsuura BS, Stephenson CR. Chemistry and biology of resveratrol-derived natural products. Chem Rev 2015; 115: 8976-9027
• 13 Cvejic JM, Djekic SV, Petrovic AV. et al Determination of trans-and cis-resveratrol in Serbian commercial wines. J Chromatogr Sci 2010; 48: 229-234
• 14 Merino E, Ribagorda M. Control over molecular motion using the cis–trans photoisomerization of the azo group. Beilstein J Org Chem 2012; 8: 1071-1090
• 15 Bernard E, Britz-McKibbin P, Gernigon N. Resveratrol photoisomerization: an integrative guided-inquiry experiment. J Chem Educ 2007; 84: 1159
• 16 Trela BC, Waterhouse AL. Resveratrol: isomeric molar absorptivities and stability. J Agric Food Chem 1996; 44: 1253-1257
• 17 Wang F, Ganesan A. Fragment based electronic structural analysis of L-phenylalanine using calculated ionization spectroscopy and dual space analysis. RSC Adv 2014; 4: 60597-60608
• 18 Yang Z, Wang F. Differentiation of alkane isomers through binding energy spectra and total momentum cross sections. RSC Adv 2014; 38: 1031-1039
• 19 Wang F. Assessment of quantum mechanical models based on resolved orbital momentum distributions of n-butane in the outer valence shell. J Phys Chem C 2003; 107: 10199-10207
• 20 Chatterjee S, Wang F. Electronic structures of hexane isomers studied using quantum mechanics and graph theory. J Theor Comput Chem 2015; 14: 1550014
• 21 Chatterjee S, Wang F. How different is pyrimidine as a core component of DNA base from its diazine isomers: A DFT study?. Int J Quantum Chem 2016; 116: 1836-1845
• 22 Islam S, Wang F. The d-electrons of Fe in ferrocene: the excess orbital energy spectrum (EOES). RSC Adv 2015; 5: 11933-11941
• 23 Khattab M, Chatterjee S, Clayton AH. et al Two conformers of a tyrosine kinase inhibitor (AG-1478) disclosed using simulated UV-Vis absorption spectroscopy. New J Chem 2016; 40: 8296-8304
• 24 Wang F, Islam S, Vasilyev V. Ferrocene orientation determined intramolecular interactions using energy decomposition analysis. Materials 2015; 8: 7723-7737
• 25 Laufer SD, Detzer A, Sczakiel G. et al Selected strategies for the delivery of siRNA in vitro and in vivo . RNA technologies and their applications 2010; 14: 29-58
• 26 Wahab A, Gao K, Jia C. et al Significance of resveratrol in clinical management of chronic diseases. Molecules 2017; 22: 1329
• 27 Fan P, Marston A, Hay AE. et al Rapid separation of three glucosylated resveratrol analogues from the invasive plant Polygonum cuspidatum by high-speed countercurrent chromatography. J Sep Sci 2009; 32: 2979-2984
• 28 Duarte A, Martinho A, Luís Â. et al Resveratrol encapsulation with methyl-β-cyclodextrin for antibacterial and antioxidant delivery applications. LWT 2015; 63: 1254-1260
• 29 Iuga C, Alvarez-Idaboy JR, Russo N. Antioxidant activity of trans-resveratrol toward hydroxyl and hydroperoxyl radicals: a quantum chemical and computational kinetics study. J Org Chem 2012; 77: 3868-3877
• 30 Yang T, Wang L, Zhu M. et al Properties and molecular mechanisms of resveratrol: a review. Pharmazie 2015; 70: 501-506
• 31 Stivala LA, Savio M, Carafoli F. et al Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem 2001; 276: 22586-22594
• 32 Fan Y, Liu Y, Gao L. et al Improved chemical stability and cellular antioxidant activity of resveratrol in zein nanoparticle with bovine serum albumin- caffeic acid conjugate. Food Chem 2018; 261: 283-291
• 33 Tabibiazar M, Mohammadifar MA, Roufegarinejad L. et al Improvement in dispersibility, stability and antioxidant activity of resveratrol using a colloidal nanodispersion of BSA-resveratrol. Food Biosci 2019; 27: 46-53
• 34 Zykova TA, Zhu F, Zhai X. et al Resveratrol directly targets COX-2 to inhibit carcinogenesis. Molecular Carcinogenesis: Published in cooperation with the University of Texas MD Anderson Cancer Center 2008; 47: 797-805
• 35 Varoni EM, Lo Faro AF, Sharifi-Rad J. et al Anticancer molecular mechanisms of resveratrol. Front. Endocrinol 2016; 3: 23-52
• 36 Jang M, Cai L, Udeani GO. et al Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997; 275: 218-220
• 37 Van Ginkel PR, Sareen D, Subramanian L. et al Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin Cancer Res 2007; 13: 5162-5169
• 38 Brisdelli F, D’Andrea G, Bozzi A. Resveratrol: a natural polyphenol with multiple chemopreventive properties. Curr Drug Metab 2009; 10: 530-546
• 39 Shukla Y, Singh R. Resveratrol and cellular mechanisms of cancer prevention. Ann N Y Acad Sci 2011; 1215: 1-8
• 40 Roccaro AM, Leleu X, Sacco A. et al Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström’s macroglobulinemia. Clin Cancer Res 2008; 14: 1849-1858
• 41 Rauf A, Imran M, Butt MS. et al Resveratrol as an anti-cancer agent: A review. Crit Rev Food Sci Nutr 2018; 58: 1428-1447
• 42 Udenigwe CC, Ramprasath VR, Aluko RE. et al Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr Rev 2008; 66: 445-454
• 43 Riba A, Deres L, Sumegi B. et al Cardioprotective effect of resveratrol in a postinfarction heart failure model. Oxid Med Cell Longev 2017; 2017: 2-10
• 44 Wu JM, Hsieh TC. Resveratrol: a cardioprotective substance. Ann N Y Acad Sci 2011; 1215: 16-21
• 45 Salehi B, Mishra AP, Nigam M. et al Resveratrol: A double-edged sword in health benefits. Biomedicines 2018; 6: 91
• 46 Hung LM, Chen JK, Huang SS. et al Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovasc Res 2000; 47: 549-555
• 47 Rauf A, Imran M, Suleria HA. et al A comprehensive review of the health perspectives of resveratrol. Food Funct 2017; 8: 4284-4305
• 48 Banez MJ, Geluz MI, Chandra A. et al A systemic review on the antioxidant and anti-inflammatory effects of resveratrol, curcumin, and dietary nitric oxide supplementation on human cardiovascular health. Nutr Res 2020; 78: 11-26
• 49 Bradamante S, Barenghi L, Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 2004; 22: 169-188
• 50 Elgendy DI, Othman AA, Saad MH. et al Resveratrol reduces oxidative damage and inflammation in mice infected with Trichinella spiralis. J Helminthol 2020; 94: 56-72
• 51 Mendez-Vilas A. Science against microbial pathogens: Communicating current research and technological advances. In Proceedings of the Formatex Research Center Badajoz Spain 2011; 693: 1348
• 52 Houille B, Papon N, Boudesocque L. et al Antifungal activity of resveratrol derivatives against Candida species. J Nat Prod 2014; 77: 1658-1662
• 53 Sun AY, Wang Q, Simonyi A. et al Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol Neurobiol 2010; 41: 375-383
• 54 Tellone E, Galtieri A, Russo A. et al Resveratrol: a focus on several neurodegenerative diseases. Oxid Med Cell Longev 2015; 2015: 5-18
• 55 Bastianetto S, Ménard C, Quirion R. Neuroprotective action of resveratrol. Biochim. Biophys. Acta, Mol Basis Dis 2015; 1852: 1195-1201
• 56 Rege SD, Geetha T, Griffin GD. et al Neuroprotective effects of resveratrol in Alzheimer disease pathology. Front Aging Neurosci 2014; 218: 145-167
• 57 Cai JC, Liu W, Lu F. et al Resveratrol attenuates neurological deficit and neuroinflammation following intracerebral hemorrhage. Exp Ther Med 2018; 15: 4131-4138
• 58 Singh N, Bansal Y, Bhandari R. et al Resveratrol protects against ICV collagenase-induced neurobehavioral and biochemical deficits. J Inflamm 2017; 14: 1-5
• 59 Gomes BA, Silva JP, Romeiro CF. et al Neuroprotective mechanisms of resveratrol in Alzheimer’s disease: role of SIRT1. Oxid Med Cell Longev 2018; 2018: 2-15
• 60 Albani D, Polito L, Signorini A. et al Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 2010; 36: 370-376
• 61 Dvorakova M, Landa P. Anti-inflammatory activity of natural stilbenoids: A review. Pharmacol Res 2017; 124: 126-145
• 62 Kong F, Zhang R, Zhao X. et al Resveratrol raises in vitro anticancer effects of paclitaxel in NSCLC cell line A549 through COX-2 expression. Korean J Physiol Pharmacol 2017; 21: 465
• 63 Zhang F, Liu J, Shi JS. Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation. Eur J Pharmacol 2010; 636: 1-7
• 64 Nunes S, Danesi F, Del Rio D. et al Resveratrol and inflammatory bowel disease: The evidence so far. Nutr Res Rev 2018; 31: 85-97
• 65 Patel KR, Brown VA, Jones DJ. et al Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 2010; 70: 7392-7399
• 66 Chen J, Cao X, Cui Y. et al Resveratrol alleviates lysophosphatidylcholine-induced damage and inflammation in vascular endothelial cells. Mol Med Rep 2018; 17: 4011-4018
• 67 Udenigwe CC, Ramprasath VR, Aluko RE. et al Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr Rev 2008; 66: 445-454
• 68 Bisht K, Wagner KH, Bulmer AC. Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto-and DNA-protective dietary compounds. Toxicology 2010; 278: 88-100
• 69 Mattio LM, Dallavalle S, Musso L. et al Antimicrobial activity of resveratrol-derived monomers and dimers against foodborne pathogens. Sci Rep 2019; 9: 1-3
• 70 Weber K, Schulz B, Ruhnke M. Resveratrol and its antifungal activity against Candida species. Mycoses 2011; 54: 30-33
• 71 Chalal M, Klinguer A, Echairi A. et al Antimicrobial activity of resveratrol analogues. Molecules 2014; 19: 7679-7688
• 72 Bostanghadiri N, Pormohammad A, Chirani AS. et al Comprehensive review on the antimicrobial potency of the plant polyphenol Resveratrol. Biomed Pharmacother 2017; 95: 1588-1595
• 73 Li T, Fan GX, Wang W. et al Resveratrol induces apoptosis, influences IL-6 and exerts immunomodulatory effect on mouse lymphocytic leukemia both in vitro and in vivo . Int Immunopharmacol 2007; 7: 1221-1231
• 74 Soto BL, Hank JA, Darjatmoko SR. et al Anti-tumor and immunomodulatory activity of resveratrol in vitro and its potential for combining with cancer immunotherapy. Int Immunopharmacol 2011; 11: 1877-1886
• 75 Gao X, Xu YX, Janakiraman N. et al Immunomodulatory activity of resveratrol: suppression of lymphocyte proliferation, development of cell- mediated cytotoxicity, and cytokine production. Biochem Pharmacol 2001; 62: 1299-1308
• 76 Kornicka K, Śmieszek A, Węgrzyn AS. et al Immunomodulatory properties of adipose-derived stem cells treated with 5-azacytydine and resveratrol on peripheral blood mononuclear cells and macrophages in metabolic syndrome animals. J Clin Med 2018; 7: 383
• 77 Gao X, Deeb D, Media J. et al Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects. Biochem Pharmacol 2003; 66: 2427-2435
• 78 Londhe JS, Devasagayam TP, Foo LY. et al Radioprotective properties of polyphenols from Phyllanthus amarus Linn. J Radiat Res 2009; 50: 303-309
• 79 Aziz MH, Afaq F, Ahmad N. Prevention of Ultraviolet-B Radiation Damage by Resveratrol in Mouse Skin Is Mediated via Modulation in Surviving. Photochem Photobiol 2005; 81: 25-31
• 80 Carsten RE, Bachand AM, Bailey SM. et al Resveratrol reduces radiation- induced chromosome aberration frequencies in mouse bone marrow cells. Radiat Res 2008; 169: 633-638
• 81 Sebastià N, Montoro A, Montoro A. et al Assessment in vitro of radioprotective efficacy of curcumin and resveratrol. Radiat Meas 2011; 46: 962-966
• 82 Sebastià N, Almonacid M, Villaescusa JI. et al Radioprotective activity and cytogenetic effect of resveratrol in human lymphocytes: An in vitro evaluation. Food Chem Toxicol 2013; 51: 391-395
• 83 Ahmad I, Anwar M, Akhter S. et al Supercritical fluid technology-based trans-resveratrol sln for long circulation and improved radioprotection. J Pharm Innov 2016; 11: 308-322
• 84 Van Ginkel PR, Sareen D, Subramanian L. et al Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin Cancer Res 2007; 13: 5162-5169
• 85 Mukherjee S, Dudley JI, Das DK. Dose-dependency of resveratrol in providing health benefits. Dose Response 2010; 8: 478-500
• 86 Brown VA, Patel KR, Viskaduraki M. et al Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: Safety, pharmacokinetics and effect on the insulin-like growth factor axis. Cancer Res 2010; 70: 9003-9011
• 87 Tomé-Carneiro J, Gonzálvez M, Larrosa M. et al Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: A triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease. Cardiovasc Drugs Ther 2013; 27: 37-48
• 88 Patel KR, Scott E, Brown VA. et al Clinical trials of resveratrol. Ann N Y Acad Sci 2011; 1215: 161-169
• 89 Bode LM, Bunzel D, Huch M. et al In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. Am J Clin Nutr 2013; 97: 295-309
• 90 Ferry-Dumazet H, Garnier O, Mamani-Matsuda M. et al Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 2002; 23: 1327-1333
• 91 Klinge CM, Blankenship KA, Risinger KE. et al Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J Biol Chem 2005; 280: 7460-7468
• 92 Pearson KJ, Baur JA, Lewis KN. et al Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending lifespan. Cell Metab 2008; 8: 157-168
• 93 La Porte C, Voduc N, Zhang G. et al Steady-state pharmacokinetics and tolerability of trans-resveratrol 2000mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clin Pharmacokinet 2010; 49: 449-454
• 94 Van Ginkel PR, Sareen D, Subramanian L. et al Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin Cancer Res 2007; 13: 5162-5169
• 95 Mukherjee S, Dudley JI, Das DK. Dose-dependency of resveratrol in providing health benefits. Dose Response 2010; 8: 478-500
• 96 Brown VA, Patel KR, Viskaduraki M. et al Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: Safety, pharmacokinetics and effect on the insulin-like growth factor axis. Cancer Res 2010; 70: 9003-9011
• 97 Tomé-Carneiro J, Gonzálvez M, Larrosa M. et al Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: A triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease. Cardiovasc Drugs Ther 2013; 27: 37-48
• 98 Patel KR, Scott E, Brown VA. et al Clinical trials of resveratrol. Ann N Y Acad Sci 2011; 1215: 161-169
• 99 Bode LM, Bunzel D, Huch M. et al In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. Am J Clin Nutr 2013; 97: 295-309
• 100 Ferry-Dumazet H, Garnier O, Mamani-Matsuda M. et al Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 2002; 23: 1327-1333